about
JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indicationsThe Ying and Yang of STAT3 in Human DiseaseSTAT5B deficiency: Impacts on human growth and immunityThe transcriptional coregulator GRIP1 controls macrophage polarization and metabolic homeostasisPediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.The genetics of nodal marginal zone lymphomaStructural basis for DNA recognition by STAT6.Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing.Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015.Genetic background and evolution of relapses in aggressive B-cell lymphomas.Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motifThe Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia.Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion.Transformed follicular lymphoma.Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma.Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation.
P2860
Q26782539-310BD866-C964-4CDF-8917-89353BCC210CQ36236873-84E24366-386F-41DD-9D29-611E79D8D363Q36840204-53FD3BB9-99D4-4AD1-A165-A3831C2A1C70Q37153637-D8C92905-286B-4E6E-8933-459C55BFBE34Q37210452-3E20A188-EC9B-4F4E-86BB-837F381B02ECQ37243257-B0C335F2-37AA-4823-B94E-F3C7405326D8Q37469583-FE16ED1E-5E0D-4A88-899C-4C2F21F66781Q37558207-9FBC7F15-775A-4925-9760-5D69F51F2AA4Q37609908-742BE29F-7A16-4004-ACAE-686A4F1900C9Q38616932-9C46FF7B-9532-463B-9A3B-1E37D6C7EB82Q38766227-4FEA8D6D-E894-4C0C-8315-D1846FEB639DQ39221094-43C34539-8ADE-4750-9EB1-C76A7BF98EE6Q39336821-E6278590-5FC0-44D5-9866-D40CF07A4BC7Q39706167-2E1FCC78-4787-40A0-B09A-637113201F7FQ40183645-CA14763C-8D34-473C-8192-6A525CEB13C7Q41843869-915588CA-A89B-4C08-9A6B-3650F2C31CC7Q42630555-CB6F7A71-C68B-4F3E-A59B-52CD7886A58FQ43090573-44DE3466-3E53-45B6-9044-DA60E03A2738Q46792686-8523ECC3-CE12-42F4-A669-F6EFBE93E64CQ47343898-E6524F40-2D6B-4393-B6E6-6E739A1D44B8Q47771789-9F74197F-AB40-43F6-BD04-7F14018463F6Q47947510-C7C25FF9-7C89-4623-B9DE-EAF2C144F5CCQ55116387-F4809395-4BF5-4818-BBCA-DF52602F4F16
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Activating STAT6 mutations in follicular lymphoma.
@en
type
label
Activating STAT6 mutations in follicular lymphoma.
@en
prefLabel
Activating STAT6 mutations in follicular lymphoma.
@en
P2093
P2860
P50
P1433
P1476
Activating STAT6 mutations in follicular lymphoma
@en
P2093
Alfred E Chang
Denzil Bernard
Hongxiu Li
Kamlai Saiya-Cork
Kathryn Jacobi
Mark S Kaminski
Mehmet Yildiz
Nisar A Amin
Peter Ouillette
Sami N Malek
P2860
P304
P356
10.1182/BLOOD-2014-06-582650
P407
P577
2014-11-26T00:00:00Z